• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Boston Scientific Corp (BSX)

Equity
Sell: $71.75|Buy: $73.3|Change: 0.82 (1.14%)

This share can be held in a Dealing accountISALifetime ISAJISASIPP

Company profile

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Address

300 Boston Scientific Way
Marlborough
MA
USA
01752-1234

Telephone

+1 508 6834479

Website

https://www.bostonscientific.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Boston Scientific Corp Annual General Meeting for 20252025-05-02T08:00:00
Boston Scientific Corp First Quarter Earnings Conference Call for 20252025-04-24T08:00:00
Boston Scientific Corp First Quarter Earnings Results for 20252025-04-24T00:00:00
Boston Scientific Corp Annual Report for 20242025-02-20T00:00:00
Boston Scientific Corp Fourth Quarter Earnings Conference Call for 20242025-01-31T08:00:00
Boston Scientific Corp Fourth Quarter Earnings Results for 20242025-01-31T00:00:00
Boston Scientific Corp Third Quarter Earnings Results for 20242024-10-25T00:00:00
Boston Scientific Corp Third Quarter Earnings Conference Call for 20242024-10-25T00:00:00
Boston Scientific Corp Second Quarter Earnings Conference Call for 20242024-07-26T07:30:00
Boston Scientific Corp Second Quarter Earnings Results for 20242024-07-26T00:00:00
Boston Scientific Corp Annual General Meeting for 20242024-05-02T08:00:00

Previous key dates

NameKey Date
Boston Scientific Corp Annual General Meeting for 20242024-05-02T08:00:00
Boston Scientific Corp First Quarter Earnings Conference Call for 20242024-04-24T08:00:00
Boston Scientific Corp First Quarter Earnings Result for 20242024-04-24T00:00:00
Boston Scientific to Participate in TD Cowen's 44th Annual Health Care Conference2024-03-06T09:10:00
Boston Scientific Corp Annual Report for 20232024-02-20T00:00:00
Boston Scientific Corp Fourth Quarter Earnings Conference Call for 20232024-01-31T08:00:00
Boston Scientific Corp Fourth Quarter Earnings Result for 20232024-01-31T00:00:00
Boston Scientific Corp Third Quarter Earnings Result for 20232023-10-26T00:00:00
Boston Scientific Corp Third Quarter Earnings Conference Call for 20232023-10-26T00:00:00
Boston Scientific Corp Second Quarter Earnings Conference Call for 20232023-07-27T07:30:00
Boston Scientific Corp Second Quarter Earnings Result for 20232023-07-27T00:00:00
Boston Scientific Corp Annual General Meeting for 20232023-05-04T08:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.